Data / Federal rules / 2024-25382
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments
The Centers for Medicare & Medicaid Services published this final rule in the Federal Register on December 9, 2024. It took effect on January 1, 2025.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
This final rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of establishment of new policies for, the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; updates to the Medicare Diabetes Prevention Program expanded model; payment for dental services inextricably linked to specific covered medical services; updates to drugs and biological products paid under Part B including immunosuppressive drugs and clotting factors; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; Medicare coverage of opioid use disorder services furnished by opioid treatment programs; updates to policies for Rural Health Clinics and Federally Qualified Health Centers; electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or a Medicare Advantage Prescription Drug (MA-PD) plan under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act); update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2023 provisions; updates to Clinical Laboratory Fee Schedule regulations; updates to the diabetes payment structure and PHE flexibilities; expansion of colorectal cancer screening and Hepatitis B vaccine coverage and payment; establishing payment for drugs covered as additional preventive services; Medicare Parts A and B Overpayment Provisions of the Affordable Care Act and Medicare Parts C and D Overpayment Provisions of the Affordable Care Act.
Key facts
- Document number
- 2024-25382
- Type
- Final rule
- Action
- Final rule
- Agency
- Health and Human Services Department; Centers for Medicare & Medicaid Services
- Published
- December 9, 2024
- Takes effect
- January 1, 2025
- Dates
- These regulations are effective on January 1, 2025.
- Docket
- CMS-1807-F and CMS-4201-F5
- Regulation ID (RIN)
- 0938-AU96; 0938-AV33
- Code of Federal Regulations
- 42 CFR 401; 42 CFR 405; 42 CFR 410; 42 CFR 411; 42 CFR 414; 42 CFR 423; 42 CFR 424; 42 CFR 425; 42 CFR 427; 42 CFR 428; 42 CFR 491
- Topics
- Administrative practice and procedure; Biologics; Claims; Diseases; Drugs; Emergency medical services; Freedom of information; Grant programs-health; Health facilities; Health maintenance organizations (HMO); Health professions; Laboratories; Medicaid; Medical devices; Medicare; Penalties; Prescription drugs; Privacy; Reporting and recordkeeping requirements; Rural areas; X-rays
- Significant
- Yes, under Executive Order 12866
- Pages
- 1348
Other documents from the Centers for Medicare & Medicaid Services
Everything from the Centers for Medicare & Medicaid Services · Rules on administrative practice and procedure · Rules on biologics · Rules on claims · Published in December 2024
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.